SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.02%66.69M | -6.92%69.34M | -8.20%70.74M | -6.13%297.85M | -8.42%72.18M | -6.82%74.12M | -7.14%74.5M | -2.11%77.06M | 5.06%317.3M | 4.07%78.81M |
Operating revenue | -10.02%66.69M | -6.92%69.34M | -8.20%70.74M | -6.13%297.85M | -8.42%72.18M | -6.82%74.12M | -7.14%74.5M | -2.11%77.06M | 5.06%317.3M | 4.07%78.81M |
Cost of revenue | -14.09%19.71M | -15.32%20.47M | -17.57%21.05M | -7.11%96.36M | -11.23%23.71M | -10.84%22.94M | -8.94%24.18M | 3.15%25.54M | 4.31%103.74M | 5.99%26.71M |
Gross profit | -8.20%46.99M | -2.89%48.87M | -3.56%49.69M | -5.65%201.49M | -6.98%48.47M | -4.90%51.18M | -6.25%50.32M | -4.52%51.52M | 5.43%213.56M | 3.11%52.1M |
Operating expense | -13.96%50.3M | -7.50%54.24M | -8.46%54.1M | 6.31%233.6M | 12.59%57.4M | 15.10%58.46M | -1.68%58.63M | 1.33%59.1M | 1.73%219.73M | 1.26%50.98M |
Selling and administrative expenses | -12.97%27.38M | -2.13%30.67M | -3.90%30.25M | -3.29%125.61M | 10.01%31.33M | 8.36%31.46M | -15.67%31.34M | -10.59%31.48M | -1.61%129.88M | -3.83%28.48M |
-Selling and marketing expense | -3.17%16.33M | 6.58%16.79M | 19.10%17.02M | 8.29%64.34M | 23.40%17.44M | 17.40%16.86M | 2.77%15.76M | -8.36%14.29M | 7.84%59.42M | 0.91%14.13M |
-General and administrative expense | -24.29%11.05M | -10.93%13.88M | -23.02%13.23M | -13.05%61.26M | -3.18%13.9M | -0.48%14.6M | -28.61%15.58M | -12.36%17.19M | -8.37%70.46M | -8.09%14.35M |
Research and development costs | -10.27%11.43M | -2.07%12.19M | -0.60%12.46M | 6.90%49.38M | 7.99%11.66M | 9.40%12.74M | 6.57%12.44M | 3.84%12.53M | 8.18%46.19M | 5.88%10.8M |
Depreciation amortization depletion | -19.44%11.49M | -23.38%11.38M | -24.50%11.4M | 34.22%58.61M | 23.13%14.41M | 40.97%14.26M | 37.50%14.85M | 36.58%15.09M | 5.70%43.67M | 11.10%11.7M |
-Depreciation and amortization | -19.44%11.49M | -23.38%11.38M | -24.50%11.4M | 34.22%58.61M | 23.13%14.41M | 40.97%14.26M | 37.50%14.85M | 36.58%15.09M | 5.70%43.67M | 11.10%11.7M |
Operating profit | 54.49%-3.31M | 35.41%-5.37M | 41.78%-4.41M | -420.16%-32.1M | -895.28%-8.93M | -339.97%-7.28M | -39.44%-8.32M | -73.74%-7.58M | 54.09%-6.17M | 507.03%1.12M |
Net non-operating interest income expense | 192.55%2.34M | 5.95%-5.06M | 9.21%-4.96M | 35.89%-18.68M | 15.19%-5.32M | 65.66%-2.53M | 30.67%-5.38M | 29.64%-5.46M | 7.84%-29.15M | 20.83%-6.28M |
Non-operating interest income | --2.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non-operating interest expense | ---- | -5.95%5.06M | -9.21%4.96M | -35.89%18.68M | -15.19%5.32M | -65.66%2.53M | -30.67%5.38M | -29.64%5.46M | -7.84%29.15M | -20.83%6.28M |
Other net income (expense) | 32.65%-229K | 111.72%198K | 32.02%-87.31M | -277.70%-131.58M | 93.61%-1.13M | 89.53%-340K | 46.35%-1.69M | -1,085.71%-128.42M | -62.13%-34.84M | -841.76%-17.61M |
Special income (charges) | --0 | --0 | 32.82%-87.23M | -287.05%-131.82M | 97.02%-451K | 87.65%-443K | 78.23%-1.07M | -1,146.99%-129.85M | -60.38%-34.06M | -522.97%-15.13M |
-Less:Restructuring and merger&acquisition | --0 | --0 | --0 | -85.80%3.06M | -82.86%451K | -87.65%443K | -78.23%1.07M | -89.49%1.09M | 1.52%21.56M | 8.36%2.63M |
-Less:Impairment of capital assets | --0 | --0 | -32.25%87.23M | 930.04%128.76M | --0 | --0 | --0 | --128.76M | --12.5M | --12.5M |
Other non- operating income (expenses) | -322.33%-229K | 132.09%198K | -105.47%-78K | 130.22%236K | 72.77%-675K | -69.62%103K | -134.72%-617K | 440.91%1.43M | -208.70%-781K | -543.47%-2.48M |
Income before tax | 88.14%-1.2M | 33.49%-10.23M | 31.66%-96.68M | -159.95%-182.37M | 32.44%-15.38M | -33.98%-10.14M | 8.81%-15.38M | -516.23%-141.47M | -5.41%-70.15M | -136.84%-22.76M |
Income tax | 136.03%530K | 619.31%1.21M | 61.53%-547K | -43.19%-2.49M | 827.59%633K | -39.30%-1.47M | 50.64%-233K | -1,028.57%-1.42M | 79.13%-1.74M | 95.93%-87K |
Net income | 80.01%-1.73M | 24.48%-11.44M | 31.36%-96.13M | -162.92%-179.87M | 29.39%-16.01M | -33.12%-8.67M | 7.60%-15.15M | -513.40%-140.05M | -17.52%-68.41M | -203.52%-22.68M |
Net income continuous Operations | 80.01%-1.73M | 24.48%-11.44M | 31.36%-96.13M | -162.92%-179.87M | 29.39%-16.01M | -33.12%-8.67M | 7.60%-15.15M | -513.40%-140.05M | -17.52%-68.41M | -203.52%-22.68M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 80.01%-1.73M | 24.48%-11.44M | 31.36%-96.13M | -162.92%-179.87M | 29.39%-16.01M | -33.12%-8.67M | 7.60%-15.15M | -513.40%-140.05M | -17.52%-68.41M | -203.52%-22.68M |
Preferred stock dividends | 4.61%1.41M | 4.59%1.39M | 4.56%1.38M | 189.65%5.35M | 4.54%1.36M | 146.15%1.34M | 1.33M | 1.32M | 1.85M | 1.3M |
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 68.65%-3.14M | 22.14%-12.83M | 31.02%-97.51M | -163.63%-185.22M | 27.55%-17.37M | -41.86%-10.01M | -0.51%-16.48M | -519.16%-141.36M | -20.70%-70.26M | -220.92%-23.98M |
Basic earnings per share | 61.29%-0.12 | 7.84%-0.47 | 23.06%-3.37 | -158.74%-5.77 | 20.00%-0.6 | -40.91%-0.31 | 1.92%-0.51 | -500.00%-4.38 | -16.15%-2.23 | -212.50%-0.75 |
Diluted earnings per share | 61.29%-0.12 | 7.84%-0.47 | 23.06%-3.37 | -158.74%-5.77 | 20.00%-0.6 | -40.91%-0.31 | 1.92%-0.51 | -500.00%-4.38 | -16.15%-2.23 | -212.50%-0.75 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |